4//SEC Filing
McMasters David 4
Accession 0001096481-11-000008
CIK 0001096481other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 6:24 PM ET
Size
19.7 KB
Accession
0001096481-11-000008
Insider Transaction Report
Form 4
McMasters David
Sr VP, Legal & General Counsel
Transactions
- Other
Stock Option w/Tandem SAR
2009-03-10−200,000→ 400,000 totalExercise: $0.27From: 2009-04-01Exp: 2014-03-09→ Common Stock (200,000 underlying) - Other
Stock Option w/Tandem SAR
2008-12-08−200,000→ 0 totalExercise: $0.16From: 2009-01-01Exp: 2013-12-07→ Common Stock (200,000 underlying) - Other
Awards (Options w/Tandem SAR)
2008-03-31−50,000→ 175,000 totalExercise: $13.47From: 2002-12-01Exp: 2012-12-17→ Common Stock (50,000 underlying) - Other
Stock Option w/Tandem SAR
2008-12-08−200,000→ 200,000 totalExercise: $0.16From: 2009-01-01Exp: 2013-12-07→ Common Stock (200,000 underlying) - Other
Common Stock
2008-03-31−2,000→ 800 total(indirect: By Spouse) - Other
Awards (Options w/Tandem SAR)
2008-03-31−175,000→ 0 totalExercise: $7.65From: 2007-03-01Exp: 2012-02-04→ Common Stock (7.65 underlying) - Other
Common Stock
2008-03-31−800→ 0 total - Other
Stock Option w/Tandem SAR
2010-03-08−135,000→ 600,000 totalExercise: $1.05From: 2010-04-01Exp: 2015-03-07→ Common Stock (135,000 underlying)
Footnotes (2)
- [F1]Effective on May 12, 2011, all of the Company's existing common shares and options to acquire common shares were canceled without any payment or consideration therefor, in connection with the implementation of a plan of compromise or arrangement under the Companies' Creditors Arrangement Act (Canada).
- [F2]Purchase price was not provided on Form 3 filing.
Documents
Issuer
ANGIOTECH PHARMACEUTICALS INC
CIK 0001096481
Entity typeother
Related Parties
1- filerCIK 0001432029
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 6:24 PM ET
- Size
- 19.7 KB